###begin article-title 0
Induction of IgG3 to LPS via Toll-Like Receptor 4 Co-Stimulation
###end article-title 0
###begin p 1
Conceived and designed the experiments: FJQ AS IRC GN. Performed the experiments: FJQ AS GN. Analyzed the data: FJQ AS IRC GN. Wrote the paper: FJQ IRC GN.
###end p 1
###begin p 2
###xml 728 736 728 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 939 946 939 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 549 553 <span type="species:ncbi:10090">mice</span>
B-cells integrate antigen-specific signals transduced via the B-cell receptor (BCR) and antigen non-specific co-stimulatory signals provided by cytokines and CD40 ligation in order to produce IgG antibodies. Toll-like receptors (TLRs) also provide co-stimulation, but the requirement for TLRs to generate T-cell independent and T-cell dependent antigen specific antibody responses is debated. Little is known about the role of B-cell expressed TLRs in inducing antigen-specific antibodies to antigens that also activate TLR signaling. We found that mice lacking functional TLR4 or its adaptor molecule MyD88 harbored significantly less IgG3 natural antibodies to LPS, and required higher amounts of LPS to induce anti-LPS IgG3. In vitro, BCR and TLR4 signaling synergized, lowering the threshold for production of T-cell independent IgG3 and IL-10. Moreover, BCR and TLR4 directly associate through the transmembrane domain of TLR4. Thus, in vivo, BCR/TLR synergism could facilitate the induction of IgG3 antibodies against microbial antigens that engage both innate and adaptive B-cell receptors. Vaccines might exploit BCR/TLR synergism to rapidly induce antigen-specific antibodies before significant T-cell responses arise.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 267 270 267 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Stavnezer1">[1]</xref>
###xml 537 540 537 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Chaudhuri1">[2]</xref>
Antibodies perform a broad array of functions dictated by the constant region of their heavy chain. Mature B cells diversify the number of functions performed by a particular antibody by switching from IgM to IgG expression while preserving their antigen specificity [1]. IgG production usually results from the integration of two signals: An antigen specific signal provided via the B-cell antigen receptor (BCR), and co-stimulatory signals provided by T cells and dendritic cells in the form of cytokines and/or membrane-bound ligands [2]. This two signal requirement limits the risk of undesired immunopathology but imposes a 5-7 day delay in the induction of an effective antibody response, a delay that might be far too long to fight fast growing pathogens.
###end p 4
###begin p 5
###xml 133 136 133 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Akira1">[3]</xref>
###xml 180 183 180 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Schnare1">[4]</xref>
###xml 196 199 196 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Caramalho1">[5]</xref>
###xml 295 298 295 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Bernasconi1">[6]</xref>
###xml 382 385 382 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Christensen1">[7]</xref>
###xml 387 390 387 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Ehlers1">[8]</xref>
###xml 392 395 392 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-He1">[9]</xref>
###xml 496 499 496 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-He1">[9]</xref>
###xml 501 505 501 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Gavin1">[10]</xref>
###xml 507 511 507 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Nemazee1">[11]</xref>
###xml 513 517 513 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Pasare1">[12]</xref>
###xml 659 673 659 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. burgdorferi</italic>
###xml 793 807 793 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. burgdorferi</italic>
###xml 837 841 837 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Alexopoulou1">[13]</xref>
###xml 288 294 <span type="species:ncbi:9606">humans</span>
###xml 659 673 <span type="species:ncbi:139">B. burgdorferi</span>
###xml 677 683 <span type="species:ncbi:9606">humans</span>
###xml 793 807 <span type="species:ncbi:139">B. burgdorferi</span>
Toll-like receptors (TLRs) and their associated signaling pathways are mostly known for their role in the control of innate immunity [3], but they also contribute to the induction [4] and control [5] of adaptive immunity. TLR signaling participates in the maintenance of B-cell memory in humans [6], and although it has been shown to facilitate switching from IgM to IgG expression [7], [8], [9], it is still unclear to what extent it is required for the induction of antigen-specific antibodies [9], [10], [11], [12]. The importance of establishing the role of TLRs in the control of the humoral response is highlighted by the outcome of vaccination against B. burgdorferi in humans: individuals with diminished TLR1/2 function showed a significant decrease in their antibody response to the B. burgdorferi OspA protein (a TLR2 ligand) [13]. In the more physiological set up of an infection, the collaboration between TLR and BCR signaling might be important for the early activation of pathogen-specific B cells that help contain the infection until the establishment of a mature T cell response.
###end p 5
###begin p 6
###xml 110 114 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Akira2">[14]</xref>
###xml 186 191 <span type="species:ncbi:10090">mouse</span>
LPS produced by Gram-negative bacteria activates B cells by way of innate TLR4 and/or TLR2 signaling pathways [14]. In this work we analyzed the contribution of TLR4 to the induction of mouse IgG antibodies to LPS. We found that IgG antibodies to LPS are induced by the synergistic interaction of low concentrations of LPS with TLR4 and the BCR. This synergism results from the association of BCR and TLR4 molecules in a B-cell membrane complex mediated by the TLR4 transmembrane domain. This mechanism might be therapeutically exploited for the induction of antigen-specific antibodies.
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Natural IgG antibodies to LPS are not detected in mice lacking a functional TLR4
###end title 8
###begin p 9
###xml 247 251 247 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Coutinho1">[15]</xref>
###xml 464 468 464 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Cohen1">[16]</xref>
###xml 470 474 470 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Macpherson1">[17]</xref>
###xml 476 480 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Ochsenbein1">[18]</xref>
###xml 482 486 482 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Ochsenbein2">[19]</xref>
IgM and IgG antibodies to self and non-self antigens can be induced by immunization, however some antibodies also arise naturally in the absence of known immunization or overt clinical disease; these antibodies have been termed natural antibodies [15]. Natural antibodies against microbial antigens are probably the result of repeated sub-clinical encounters with normal flora and infectious agents, and have been shown to be effective in the control of infection [16], [17], [18], [19].
###end p 9
###begin p 10
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Hoshino1">[20]</xref>
###xml 164 168 164 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Qureshi1">[21]</xref>
###xml 290 295 290 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P712H</sup>
###xml 290 295 290 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>P712H</sup></italic>
###xml 325 327 325 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 325 327 325 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 382 390 382 390 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table S1</bold>
###xml 382 390 382 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003509.s001"><bold>Table S1</bold></xref>
###xml 532 534 532 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 532 534 532 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 579 584 579 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P712H</sup>
###xml 579 584 579 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>P712H</sup></italic>
###xml 591 600 591 600 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1A</bold>
###xml 591 600 591 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g001"><bold>Figure 1A</bold></xref>
###xml 676 685 676 685 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1B</bold>
###xml 676 685 676 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g001"><bold>Figure 1B</bold></xref>
###xml 834 843 834 843 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1B</bold>
###xml 834 843 834 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g001"><bold>Figure 1B</bold></xref>
###xml 940 945 940 945 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P712H</sup>
###xml 940 945 940 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>P712H</sup></italic>
###xml 993 1002 993 1002 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1C</bold>
###xml 993 1002 993 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g001"><bold>Figure 1C</bold></xref>
###xml 1002 1003 1002 1003 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 1046 1051 1046 1051 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P712H</sup>
###xml 1046 1051 1046 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>P712H</sup></italic>
###xml 1166 1170 1163 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Scott1">[22]</xref>
###xml 1269 1278 1266 1275 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1D</bold>
###xml 1269 1278 1266 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g001"><bold>Figure 1D</bold></xref>
###xml 1428 1432 1425 1429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Durham1">[23]</xref>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 120 125 <span type="species:ncbi:10090">mouse</span>
###xml 329 333 <span type="species:ncbi:10090">mice</span>
###xml 409 413 <span type="species:ncbi:10090">mice</span>
###xml 535 539 <span type="species:ncbi:10090">mice</span>
###xml 585 589 <span type="species:ncbi:10090">mice</span>
###xml 670 674 <span type="species:ncbi:10090">mice</span>
###xml 1052 1056 <span type="species:ncbi:10090">mice</span>
C3H/HeJ mice harbor a P712H point mutation in the TLR4 gene that results in a non-functional protein, whereas other C3H mouse strains express functional TLR4 [20], [21]. We probed the repertoire of natural IgG antibodies in pooled sera from non-immunized 14-week old C3H/HeJ (hereafter TLR4P712H) or C3HeB/FeJ (hereafter TLR4WT) mice using a panel of 87 self and non-self antigens (Table S1). Both strains of mice harbored similar profiles of natural IgG antibodies except for antibodies to LPS that were present in the sera of TLR4WT mice, but not detectable in the sera of TLR4P712H mice (Figure 1A). This strain difference was confirmed by testing sera of individual mice (Figure 1B). Surprisingly, there were no differences in the levels of anti-LPS IgM between the two strains despite the significant difference in anti-LPS IgG (Figure 1B). To rule out a prozone effect, sera were serially diluted and tested for anti-LPS IgG. The TLR4P712H sera were not reactive to LPS at any dilution (Figure 1C). The lack of IgG reactivity to LPS in TLR4P712H mice was not due to masking of LPS epitopes by IgM because sera were pre-treated with 0.05 M beta-mercaptoethanol [22] to disrupt IgM. The natural anti-LPS IgG antibodies were almost exclusively of the IgG3 subclass (Figure 1D), and recognized an oxidation sensitive epitope (data not shown), as has been previously described for antibodies to the carbohydrate portion of LPS [23].
###end p 10
###begin title 11
###xml 56 61 56 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P712H</sup>
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>P712H</sup></italic>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
Natural IgG antibodies to LPS are not detectable in TLR4P712H mice.
###end title 11
###begin p 12
###xml 65 67 65 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 65 67 65 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 77 82 77 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P712H</sup>
###xml 77 82 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>P712H</sup></italic>
###xml 140 142 140 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 140 142 140 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 152 157 152 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P712H</sup>
###xml 152 157 152 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>P712H</sup></italic>
###xml 175 176 175 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 204 206 204 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 204 206 204 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 271 273 271 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 271 273 271 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 282 287 282 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P712H</sup>
###xml 282 287 282 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>P712H</sup></italic>
###xml 314 315 314 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 329 330 329 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 358 360 358 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 358 360 358 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 423 425 423 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 423 425 423 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 435 440 435 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P712H</sup>
###xml 435 440 435 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>P712H</sup></italic>
###xml 457 458 457 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 485 487 485 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 485 487 485 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 574 575 574 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 602 604 602 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 602 604 602 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
###xml 361 365 <span type="species:ncbi:10090">mice</span>
###xml 441 445 <span type="species:ncbi:10090">mice</span>
###xml 488 492 <span type="species:ncbi:10090">mice</span>
###xml 605 609 <span type="species:ncbi:10090">mice</span>
A. IgG reactivity in pooled blood samples from non-immunized TLR4WT and TLR4 P712H mice. B. IgM and IgG antibodies to LPS in individual TLR4WT and TLR4 P712H mice (n = 5, *** P<0.001 when compared to TLR4WT mice). C. Titration of spontaneous IgG antibodies to LPS in TLR4WT and TLR4P712H mice (n = 5 per group, ** P<0.01 and *** P<0.001 when compared to TLR4WT mice). D. IgG subclass of antibodies to LPS in individual TLR4WT and TLR4 P712H mice (n = 5, ** P<0.01 when compared to TLR4WT mice). E. Time course of the induction of IgG3 antibodies to LPS (n = 6 per group, ** P<0.01 when compared to TLR4WT mice).
###end p 12
###begin p 13
###xml 54 63 54 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1E</bold>
###xml 54 63 54 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g001"><bold>Figure 1E</bold></xref>
###xml 269 271 269 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 269 271 269 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 309 314 309 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P712H</sup>
###xml 309 314 309 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>P712H</sup></italic>
###xml 343 352 343 352 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1E</bold>
###xml 343 352 343 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g001"><bold>Figure 1E</bold></xref>
###xml 272 276 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
We analyzed the appearance of anti-LPS IgG over time (Figure 1E). At 4 weeks of age, anti-LPS IgG was not detectable in either strain, however both strains manifested anti-LPS IgM (data not shown). Starting at week 8, anti-LPS IgG was detectable in the sera of the TLR4WT mice, but not in the sera of the TLR4P712H mice, through age 16 weeks (Figure 1E).
###end p 13
###begin p 14
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Snapper1">[24]</xref>
Based on these results, and taking into consideration that LPS is a T cell independent antigen known to elicit primarily IgM and IgG3 antibodies [24], we focused our investigations on the role of TLR4 in the generation of IgG3 to LPS.
###end p 14
###begin title 15
The synthesis of anti-LPS IgG3 involves MyD88-dependant TLR4 signaling
###end title 15
###begin p 16
###xml 299 308 299 308 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S1</bold>
###xml 299 308 299 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003509.s002"><bold>Figure S1</bold></xref>
###xml 479 483 479 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Quintana1">[25]</xref>
###xml 549 553 549 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Quintana1">[25]</xref>
###xml 707 712 707 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P712H</sup>
###xml 707 712 707 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>P712H</sup></italic>
###xml 932 936 928 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Krieg1">[26]</xref>
###xml 955 964 951 960 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2A</bold>
###xml 955 964 951 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g002"><bold>Figure 2A</bold></xref>
###xml 974 979 970 975 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P712H</sup>
###xml 974 979 970 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>P712H</sup></italic>
###xml 1026 1028 1022 1024 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 1026 1028 1022 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 1102 1104 1098 1100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 1102 1104 1098 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 1168 1177 1164 1173 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2B</bold>
###xml 1168 1177 1164 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g002"><bold>Figure 2B</bold></xref>
###xml 1238 1243 1234 1239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P712H</sup>
###xml 1238 1243 1234 1239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>P712H</sup></italic>
###xml 1255 1257 1251 1253 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 1255 1257 1251 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 1366 1375 1362 1371 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2C</bold>
###xml 1366 1375 1362 1371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g002"><bold>Figure 2C</bold></xref>
###xml 216 220 <span type="species:ncbi:10090">mice</span>
###xml 248 252 <span type="species:ncbi:10090">mice</span>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
###xml 438 442 <span type="species:ncbi:10090">mice</span>
###xml 495 499 <span type="species:ncbi:10090">mice</span>
###xml 908 914 <span type="species:ncbi:10090">murine</span>
###xml 1105 1109 <span type="species:ncbi:10090">mice</span>
###xml 1258 1262 <span type="species:ncbi:10090">mice</span>
To confirm that the difference in anti-LPS IgG was due to the differences in the TLR4 gene and not to other genetic differences between the C3H sub-strains, we back-crossed the TLR4 P712H point mutation from C3H/HeJ mice onto the genome of NOD/LtJ mice that normally bear functional wild-type TLR4 (Figure S1). We previously demonstrated that NOD mice develop anti-LPS IgG by 8 weeks of age in the absence of immunization, just as do C3H mice homozygous for wild-type TLR4 genes [25]. Since NOD mice develop a rich network of natural autoantibodies [25], we could test the impact that loss of TLR4 signaling has upon these reactivities. Breeding the mutant TLR4 allele into the NOD/LtJ genome (hereafter NODP712H) specifically impaired their B-cell proliferative response to LPS, whereas proliferation induced by a mitogenic antibody to surface IgM (alphaIgM), or by a CpG oligonucleotide (known to activate murine B-cells via TLR9 [26]) remained intact (Figure 2A). The NODP712H and littermates bearing WT TLR4 (hereafter NODWT) all developed anti-LPS IgM antibodies (data not shown), but only the NODWT mice developed anti-LPS IgG: IgG3 and to a lower extent, IgG1 (Figure 2B). Regardless of the functionality of their TLR4 both the NODP712H and the NODWT mice spontaneously developed IgG antibodies that bound the self-antigens GAD, Histone IIA, dsDNA and ssDNA (Figure 2C), among others. Thus although both strains were equally exposed to LPS, as suggested by the similar levels of LPS-reactive IgM, functional TLR4 is specifically needed for the spontaneous development of natural anti-LPS IgG antibodies.
###end p 16
###begin title 17
Natural Anti-LPS IgG3 is generated via MyD88-dependant TLR4 signaling.
###end title 17
###begin p 18
###xml 29 34 29 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P712H</sup>
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>P712H</sup></italic>
###xml 42 44 42 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 42 44 42 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 65 73 65 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 147 148 143 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 174 176 170 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 174 176 170 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 238 240 234 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 238 240 234 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 258 263 254 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P712H</sup>
###xml 258 263 254 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>P712H</sup></italic>
###xml 282 283 278 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 310 312 306 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 310 312 306 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 380 382 376 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 380 382 376 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 400 405 396 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P712H</sup>
###xml 400 405 396 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>P712H</sup></italic>
###xml 457 460 453 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 470 473 466 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 492 493 488 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 527 530 523 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
###xml 264 268 <span type="species:ncbi:10090">mice</span>
###xml 313 317 <span type="species:ncbi:10090">mice</span>
###xml 406 410 <span type="species:ncbi:10090">mice</span>
###xml 474 478 <span type="species:ncbi:10090">mice</span>
###xml 531 535 <span type="species:ncbi:10090">mice</span>
A. Purified B cells from NOD P712H and NODWT mice were activated in vitro with LPS, CpG or alphaIgM and the proliferative response was assayed. ** P<0.01 when compared to NODWT mice. B. Total IgG and IgG1 vs. IgG3 antibodies to LPS in NODWT (n = 13) and NOD P712H mice (n = 7). *** P<0.001 when compared to NODWT mice. C. IgG antibodies to GAD, histone IIA, dsDNA and ssDNA in NODWT (n = 13) and NOD P712H mice (n = 7). D. IgG3 antibodies to LPS in WT, TLR2-/- and MyD88-/- mice (n = 4). *** P<0.001 when compared to WT or TLR2-/- mice. Results represent mean (+/-SD) of each group.
###end p 18
###begin p 19
###xml 77 90 77 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. gingivalis</italic>
###xml 138 141 138 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Akira1">[3]</xref>
###xml 235 238 235 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Akira1">[3]</xref>
###xml 240 244 240 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Akira2">[14]</xref>
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Akira2">[14]</xref>
###xml 577 586 577 586 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2D</bold>
###xml 577 586 577 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g002"><bold>Figure 2D</bold></xref>
###xml 689 698 689 698 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2D</bold>
###xml 689 698 689 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g002"><bold>Figure 2D</bold></xref>
###xml 77 90 <span type="species:ncbi:837">P. gingivalis</span>
###xml 497 501 <span type="species:ncbi:10090">mice</span>
###xml 598 602 <span type="species:ncbi:10090">mice</span>
TLR2 governs the innate response to LPS from gram-negative organisms such as P. gingivalis (pgLPS) and to lipoproteins and peptidoglycans [3]. Both TLR2- and TLR4-dependent signaling pathways operate through the adaptor molecule MyD88 [3], [14], although TLR4 signaling can proceed through a MyD88-independent pathway [14]. To confirm the specificity of the control by TLR4 of the induction of anti-LPS IgG3 antibodies we followed the induction of natural IgG3 antibodies to LPS in TLR2-deficient mice: no difference was seen in their levels when compared to matched controls (Figure 2D). However, mice deficient in the intracellular adaptor protein MyD88 failed to develop anti-LPS IgG3 (Figure 2D), although they did develop natural anti-LPS IgM (data not shown). Thus, the appearance of IgG3 LPS-specific antibodies is TLR2 independent and is controlled by TLR4 via the MyD88 pathway.
###end p 19
###begin title 20
TLR4 controls the response to LPS upon immunization
###end title 20
###begin p 21
###xml 140 142 140 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 140 142 140 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 150 155 150 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P712H</sup>
###xml 150 155 150 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>P712H</sup></italic>
###xml 184 193 184 193 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1C</bold>
###xml 184 193 184 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g001"><bold>Figure 1C</bold></xref>
###xml 226 235 226 235 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3A</bold>
###xml 226 235 226 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g003"><bold>Figure 3A</bold></xref>
###xml 407 414 399 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 435 448 423 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. gingivalis</italic>
###xml 558 565 542 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 614 616 598 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 614 616 598 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 652 669 636 653 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figures 3B and 3D</bold>
###xml 652 669 636 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g003"><bold>Figures 3B and 3D</bold></xref>
###xml 736 741 716 721 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P712H</sup>
###xml 736 741 716 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>P712H</sup></italic>
###xml 783 792 763 772 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3B</bold>
###xml 783 792 763 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g003"><bold>Figure 3B</bold></xref>
###xml 808 810 788 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 808 810 788 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 823 828 803 808 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P712H</sup>
###xml 823 828 803 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>P712H</sup></italic>
###xml 939 948 915 924 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3C</bold>
###xml 939 948 915 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g003"><bold>Figure 3C</bold></xref>
###xml 1074 1076 1050 1052 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 1074 1076 1050 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 1083 1092 1059 1068 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3D</bold>
###xml 1083 1092 1059 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g003"><bold>Figure 3D</bold></xref>
###xml 1121 1128 1097 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1215 1222 1191 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1284 1291 1260 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
###xml 251 255 <span type="species:ncbi:10090">mice</span>
###xml 339 343 <span type="species:ncbi:10090">mice</span>
###xml 407 414 <span type="species:ncbi:562">E. coli</span>
###xml 435 448 <span type="species:ncbi:837">P. gingivalis</span>
###xml 489 494 <span type="species:ncbi:10090">mouse</span>
###xml 558 565 <span type="species:ncbi:562">E. coli</span>
###xml 617 621 <span type="species:ncbi:10090">mice</span>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
###xml 829 833 <span type="species:ncbi:10090">mice</span>
###xml 1077 1081 <span type="species:ncbi:10090">mice</span>
###xml 1121 1128 <span type="species:ncbi:562">E. coli</span>
###xml 1215 1222 <span type="species:ncbi:562">E. coli</span>
###xml 1264 1268 <span type="species:ncbi:10090">mice</span>
###xml 1284 1291 <span type="species:ncbi:562">E. coli</span>
###xml 1450 1454 <span type="species:ncbi:10090">mice</span>
We tested whether functional TLR4 was also needed for the induction of IgG3 by deliberate immunization to LPS. We immunized 1-month old TLR4WT or TLR4P712H mice with LPS. At this age (Figure 1C) and throughout the experiment (Figure 3A), un-immunized mice of both strains were still negative for natural anti-LPS IgG antibodies. Groups of mice received a single high (1 microg) or low (0.01 microg) dose of E. coli LPS, or 1 microg of P. gingivalis LPS (pgLPS), or PBS, and we assayed the mouse sera for anti-LPS antibodies. Immunization with 0.01 microg of E. coli LPS sufficed to induce anti-LPS IgG3 in the TLR4WT mice, and to a lesser extent IgG1 (Figures 3B and 3D). In contrast, the 0.01 microg dose of LPS did not induce the TLR4P712H mice to produce anti-LPS IgG antibodies (Figure 3B). Both the TLR4WT and the TLR4P712H mice produced anti-LPS IgG (detected at a dilution of 1:100) upon immunization with the 1 microg dose of LPS (Figure 3C). Nevertheless, serial dilutions of the sera demonstrated that the anti-LPS IgG3 titers were significantly higher in the TLR4WT mice (Figure 3D, p<0.05). The antibodies to E. coli LPS were specific; immunization with pgLPS did not induce significant levels of anti- E. coli LPS IgG antibodies in either strain, and mice immunized with E. coli LPS did not manifest cross-reactivity to pgLPS (data not shown). Moreover, no differences in LPS-specific IgM levels were detected between the two strains of mice upon immunization with the 0.01 microg or the 1 microg dose of LPS (data not shown). These results indicate that TLR4 signaling is critical not only for natural anti-LPS IgG3 antibodies but also for the induction of anti-LPS IgG3 antibodies in situations where antigen availability is the limiting factor. Higher doses of LPS can apparently generate IgG3 antibodies by other signaling pathways, although the antibody titer, often a critical factor in protection, is still controlled by the TLR4-generated signal.
###end p 21
###begin title 22
TLR4 and BCR synergize.
###end title 22
###begin p 23
###xml 9 11 9 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 9 11 9 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 20 25 20 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P712H</sup>
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>P712H</sup></italic>
###xml 212 213 204 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 240 242 232 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 240 242 232 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 454 455 440 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 483 485 469 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 483 485 469 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 528 530 514 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 528 530 514 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 551 559 537 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 747 748 725 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 869 874 839 844 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P712H</sup>
###xml 869 874 839 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>P712H</sup></italic>
###xml 895 903 865 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 102 107 <span type="species:ncbi:10090">mouse</span>
###xml 130 135 <span type="species:ncbi:10090">mouse</span>
###xml 243 247 <span type="species:ncbi:10090">mice</span>
###xml 366 371 <span type="species:ncbi:10090">mouse</span>
###xml 486 490 <span type="species:ncbi:10090">mice</span>
###xml 531 535 <span type="species:ncbi:10090">mice</span>
###xml 875 879 <span type="species:ncbi:10090">mice</span>
A-C. TLR4WT and TLR4P712H mice were left untreated (A) or immunized with a single low (B, 0.01 microg/mouse) or high (C, 1 microg/mouse) dose of LPS in PBS and IgG3 antibodies to LPS were determined by ELISA. ** P<0.01 when compared to TLR4WT mice. D. The titer of antibodies to LPS was determined in the serum samples taken 12 days after immunization with 1 microg/mouse of LPS. Results represent the mean (+/-SD) of each experimental group (n = 5, *** P<0.001 when compared to TLR4WT mice). E and F. Purified B cells from TLR4WT mice were activated in vitro with LPS, alphaIgM (aIgM), LPS and alphaIgM (LPS+aIgM) or the [LPS-aIgM] conjugate (conjugate) for 48 hr, and the supernatants were assayed for the secretion of IgG3 (E) or IL-10 (F). ** P<0.01 when compared to cells treated with LPS, alphaIgM (aIgM) or LPS and alphaIgM (LPS+aIgM). Purified B cells from TLR4P712H mice were activated in vitro with LPS, alphaIgM (aIgM), LPS and alphaIgM (LPS+aIgM) or the [LPS-aIgM] conjugate (conjugate) for 48 hr, and the supernatants were assayed for the secretion of IgG3 (G) or IL-10 (H).
###end p 23
###begin title 24
TLR4 and BCR synergize
###end title 24
###begin p 25
###xml 253 257 253 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Miner1">[27]</xref>
###xml 793 801 789 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 963 972 955 964 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S2</bold>
###xml 963 972 955 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003509.s003"><bold>Figure S2</bold></xref>
###xml 978 982 970 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Ulevitch1">[28]</xref>
###xml 1074 1078 1066 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Briere1">[29]</xref>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
LPS is composed of a lipid A moiety connected to chains of polysaccharide. Lipid A is responsible for the toxic effects of LPS and the B-cell mitogenic effect, however it is virtually non-immunogenic; antibodies to LPS bind to the polysaccharide chains [27]. The finding that TLR4 signaling is needed for the induction of IgG3 antibodies to LPS in intact mice suggested that the innate TLR4, activated by the lipid A component of LPS, and the adaptive BCR molecules that recognize polysaccharide LPS epitopes, might interact together in responding B cells during activation. To test this hypothesis, we studied the responses of purified B cells to LPS and/or BCR stimulation in vitro. We simulated BCR antigen-activation using mitogenic anti-IgM antibodies (alphaIgM) that cross-link the BCR. In vitro, alphaIgM does not induce isotype switching to IgG3 whereas LPS is a mitogenic signal that does induce switching to IgG3, but at relatively high concentrations (Figure S2 and ([28]). IgG3 synthesis is known to require the autocrine secretion of IL-10 by activated B-cells [29]. Thus we could use alphaIgM and LPS to detect possible synergistic effects of the activation of BCR- and TLR4-dependent signaling pathways, respectively.
###end p 25
###begin p 26
###xml 4 12 4 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 70 72 70 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 70 72 70 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 80 85 80 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P712H</sup>
###xml 80 85 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>P712H</sup></italic>
###xml 727 736 715 724 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S3</bold>
###xml 727 736 715 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003509.s004"><bold>Figure S3</bold></xref>
###xml 789 791 773 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 789 791 773 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 888 905 872 889 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figures 3E and 3F</bold>
###xml 888 905 872 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g003"><bold>Figures 3E and 3F</bold></xref>
###xml 1018 1023 1002 1007 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P712H</sup>
###xml 1018 1023 1002 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>P712H</sup></italic>
###xml 1061 1078 1045 1062 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figures 3G and 3H</bold>
###xml 1061 1078 1045 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g003"><bold>Figures 3G and 3H</bold></xref>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
For in vitro experiments, we purified B cells from the spleens of TLR4WT or TLR4P712H mice, and then measured B-cell proliferation, secretion of IL-10 and production of IgG3 in response to the following agents: LPS alone, alphaIgM alone, mixtures of LPS and alphaIgM, and LPS conjugated to alphaIgM. The conjugate simulates the encounter of LPS by a B-cell bearing a BCR specific for the polysaccharide since the antigenic polysaccharide epitope and the lipidic TLR4 ligand are covalently bound in the LPS molecule. The purified population of B cells was free of T cells or macrophages (data not shown), and thus there was no T-cell help. Surprisingly, despite no differences in B-cell proliferation to these mitogenic agents (Figure S3), the LPS-alphaIgM conjugate triggered only the TLR4WT B cells to secrete significantly higher levels of IL-10 and IgG3 compared to the other stimuli (Figures 3E and 3F). The effect of the conjugate was mediated by TLR4: we did not detect IL-10 or IgG3 secretion from purified TLR4P712H B-cells stimulated by the conjugate (Figures 3G and 3H). Since conjugation of the two mitogens was required to induce the production of IgG3, it was likely that co-ligation of TLR4 and BCR was sufficient to activate the IgM to IgG3 switching mechanism in the absence of T cells.
###end p 26
###begin title 27
TLR4 and BCR associate on the B cell membrane
###end title 27
###begin p 28
###xml 95 99 95 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Rickert1">[30]</xref>
###xml 248 252 248 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Rickert1">[30]</xref>
###xml 433 441 433 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 505 515 505 515 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S4A</bold>
###xml 505 515 505 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003509.s005"><bold>Figure S4A</bold></xref>
###xml 638 642 638 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Ogata1">[31]</xref>
Costimulation of B cells through different co-receptors is known to modulate B cell activation [30]. The CD19-CD21 complex, for example, co-clusters with the BCR upon interaction with complement-tagged antigens resulting in increased BCR signaling [30], thus we studied the surface distribution of the BCR and TLR4 molecules by confocal microscopy. Membrane IgM and TLR4 molecules capped together on the surface of B-cells following in vitro activation with LPS; these caps also contain FITC-labeled LPS (Figure S4A). An additional TLR family member expressed on B cells, RP105, was not recruited to the LPS-induced caps (data not shown) [31]. Thus, B-cell activation by LPS triggers the co-localization of TLR4 and BCR molecules.
###end p 28
###begin p 29
###xml 192 195 192 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 192 195 192 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del</sup></italic>
###xml 205 214 205 214 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4A</bold>
###xml 205 214 205 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g004"><bold>Figure 4A</bold></xref>
###xml 214 219 214 219 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> and </bold>
###xml 219 229 219 229 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S4B</bold>
###xml 219 229 219 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003509.s005"><bold>Figure S4B</bold></xref>
###xml 301 306 301 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P712H</sup>
###xml 301 306 301 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>P712H</sup></italic>
###xml 846 848 846 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 846 848 846 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 881 884 881 884 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 881 884 881 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del</sup></italic>
###xml 899 908 899 908 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4B</bold>
###xml 899 908 899 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g004"><bold>Figure 4B</bold></xref>
###xml 767 772 <span type="species:ncbi:10090">mouse</span>
To confirm these results, we performed immuno-precipitation and pull-down assays. IgM and TLR4 were co-precipitated from extracts prepared from wild-type LPS-treated B cells, but not from TLR4del B-cells (Figure 4A and Figure S4B). No co-precipitation was detected using extracts from LPS-treated TLR4P712H B cells, suggesting that physical association depends on functional signaling through TLR4 (data not shown). To confirm these results, we preincubated cell extracts from LPS activated (or control) B cells with biotinylated antibodies to TLR4, and then captured the biotinylated antibody-antigen complexes on streptavidin coated microtiter plates. The plates where washed and the BCR molecules pulled-down with TLR4 were quantified using an HRP-conjugated anti-mouse IgM detection antibody. TLR4/IgM complexes could be pulled down from TLR4WT B cells, but not from their TLR4del counterparts (Figure 4B). These results suggest that the TLR4 and IgM molecules are associated on the surface of LPS-activated B cells, either directly or through yet uncharacterized interaction partners.
###end p 29
###begin title 30
TLR4 and BCR interact in the membrane of LPS-activated B-cells.
###end title 30
###begin p 31
###xml 29 31 29 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 29 31 29 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 39 42 39 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 39 42 39 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del</sup></italic>
###xml 271 273 267 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 271 273 267 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 281 284 277 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 281 284 277 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del</sup></italic>
###xml 538 539 530 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 552 553 544 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 285 289 <span type="species:ncbi:10090">mice</span>
A. Purified B cells from TLR4WT or TLR4del mice were incubated for 1 hr with 0, 0.1 or 1 microg/ml of LPS, TLR4 was immunoprecipitated and bound proteins were separated by PAGE-SDS and analyzed by western blot using an IgM-specific antibody. D. Purified B cells from TLR4WT or TLR4del mice were incubated for 1 hr with 0, 0.1 or 1 microg/ml of LPS, TLR4 was immunoprecipitated with a specific biotinylated antibody and then captured on streptavidin-coated microplates and bound IgM was detected with a specific HRP-conjugated antibody. * P<0.05 and ** P<0.01 vs. control (no LPS).
###end p 31
###begin title 32
TLR4/BCR association does not require CD14 and MD-2 and is specific to TLR4
###end title 32
###begin p 33
###xml 295 304 295 304 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5A</bold>
###xml 295 304 295 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g005"><bold>Figure 5A</bold></xref>
###xml 412 421 412 421 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5B</bold>
###xml 412 421 412 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g005"><bold>Figure 5B</bold></xref>
###xml 423 427 423 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Fang1">[32]</xref>
###xml 481 485 481 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Smith1">[33]</xref>
###xml 670 679 670 679 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5C</bold>
###xml 670 679 670 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g005"><bold>Figure 5C</bold></xref>
###xml 719 728 719 728 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5D</bold>
###xml 719 728 719 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g005"><bold>Figure 5D</bold></xref>
###xml 1299 1308 1299 1308 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5E</bold>
###xml 1299 1308 1299 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g005"><bold>Figure 5E</bold></xref>
###xml 1384 1392 1384 1392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g004">Figure 4</xref>
###xml 1559 1563 1559 1563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Smith1">[33]</xref>
###xml 1949 1953 1949 1953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Pierce1">[34]</xref>
To characterize the components involved in the interaction between TLR4 and BCR, we used the non-lymphoid HEK293 cell line. Transfection of HEK293 cells with vectors coding for the IgM heavy and light chains (HC and LC, respectively) leads to the cytoplasmic localization of the newly made IgM (Figure 5A); the IgM is relocalized to the cell surface upon co-transfection with vectors coding for CD79a and CD79b (Figure 5B) [32]. Since HEK293 cells can also express functional TLR4 [33], we studied whether the interaction between TLR4 and the BCR might result in changes in the localization of these molecules. Transfection of HEK293 cells with vectors coding for TLR4 (Figure 5C) alone or together with IgM HC and LC (Figure 5D) led to the cytoplasmic expression of the newly synthesized proteins. The cytoplasmic localization of TLR4 in HEK293 cells has been reported previously and may be related to the absence of additional components of the LPS receptor complex in these cells (find ref). In any case, the cytoplasmic location of TLR4 when expressed alone or together with IgM HC and LC dramatically shifted when TLR4 was co-transfected with IgM HC and LC together with CD79a and CD79b. Co-transfection led to the translocation of both the newly synthesized IgM and TLR4 to the cell membrane (Figure 5E). Thus, the interaction evidenced by co-precipitation experiments shown in Figure 4 appears to be operational in HEK293 cells, allowing BCR molecules to drag the TLR4 to the cell surface. Since the transfected cells express TLR4 but not CD14 or MD-2 [33], these components of the LPS receptor complex do not appear to be involved in the TLR4 association with the BCR. Note however, that in HEK293 cells TLR4 physically associated with the BCR in the absence of LPS stimulation, probably as a result of the over-expression of the transfected molecules or because of differences in membrane microdomains of this cell line and primary B cells [34].
###end p 33
###begin title 34
TLR4 and BCR are physically associated.
###end title 34
###begin p 35
###xml 177 182 <span type="species:ncbi:10090">mouse</span>
###xml 256 261 <span type="species:ncbi:9606">human</span>
HEK293 cells were transfected with BCR and HA-tagged TLR constructs, fixed, mounted, and examined by confocal microscopy. TLR staining (anti-HA followed by Cy3-conjugated anti- mouse IgG) was pseudo-colored green and IgM staining (with Cy5-conjugated anti-human IgM) was pseudo-colored red. Panels showing TLR/BCR co-transfection experiments (D-E and G-H) represent an overlay of the green and red channels. A and B. IgM HC and LC constructs (BCR, shown in A) are fully cytoplasmic (A) but they are shifted to the membrane upon transfection with CD79a and CD79b coding constructs (B, arrow). C-H. HA-tagged TLR4 (C-E) or TLR9 (F-H) were transfected alone (C and F) or co-transfected with the IgM HC and LC constructs (D and G) or HC/LC+CD79a/CD79b (E and H). HA-tagged TLR4 (C-E), but not HA-tagged TLR9 (F-H), is dragged to the membrane upon cotransfection with CD79a and CD79b coding constructs.
###end p 35
###begin p 36
###xml 65 68 65 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Christensen1">[7]</xref>
###xml 70 73 70 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Ehlers1">[8]</xref>
###xml 75 79 75 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Leadbetter1">[35]</xref>
###xml 81 85 81 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Rifkin1">[36]</xref>
###xml 87 91 87 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Viglianti1">[37]</xref>
###xml 328 340 328 340 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figures 5F&#8211;H</bold>
###xml 328 340 328 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g005"><bold>Figures 5F&#8211;H</bold></xref>
###xml 509 513 509 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Latz1">[38]</xref>
###xml 948 952 948 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Latz1">[38]</xref>
###xml 954 958 954 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Chaturvedi1">[39]</xref>
Since synergism between the BCR and TLR9 has also been described [7], [8], [35], [36], [37], we studied whether TLR9 could interact with the BCR in HEK293 cells. In contrast to TLR4, co-transfection of HA-tagged TLR9 with IgM HC/LC and CD79a/CD79b, led to the cytoplasmic expression of TLR9 and surface localization of the IgM (Figures 5F-H). This suggests that TLR9 does not associate physically with the BCR in this system. Since TLR9 is known to localize to intracellular compartments in all cells studied [38], overexpression in HEK293 cells with the BCR would not be expected to shift its expression to the cell surface. The fact that TLR9 expression remained intracellular validated the use of HEK293 transfectants in this study of TLR trafficking and localization. Nevertheless, in B cells the BCR is internalized following antigen cross-linking and direct or indirect interaction with intracellular TLR9 may underlie the synergistic signal [38], [39].
###end p 36
###begin title 37
The transmembrane domain of TLR4 mediates the interaction with the BCR
###end title 37
###begin p 38
###xml 464 480 464 480 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figures 6A and B</bold>
###xml 464 480 464 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g006"><bold>Figures 6A and B</bold></xref>
###xml 495 511 495 511 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figures 6C and D</bold>
###xml 495 511 495 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g006"><bold>Figures 6C and D</bold></xref>
###xml 526 543 526 543 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figures 6E and 6F</bold>
###xml 526 543 526 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g006"><bold>Figures 6E and 6F</bold></xref>
###xml 1039 1050 1039 1050 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 7A&#8211;D</bold>
###xml 1039 1050 1039 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g007"><bold>Figure 7A&#8211;D</bold></xref>
To map the domain in the TLR4 molecule responsible for the TLR4/BCR interaction, we studied the ability of truncated TLR4 proteins to interact with IgM and relocalize to the membrane of HEK293 cells upon cotransfection with CD79a and CD79b. We used HA-tagged TLR deletion mutants containing the extracellular and transmembrane domains (named TLR4 EC-TM), intracellular and transmembrane domains (TLR4 TM-IC) or only the transmembrane domain (TLR4 TM). TLR4 TM-IC (Figures 6A and B), TLR4 EC-TM (Figures 6C and D) and TLR4 TM (Figures 6E and 6F) trafficked to the membrane when IgM HC and LC were co-expressed with CD79a and CD79b, suggesting that the TLR4-BCR interaction is mediated by the TLR4 transmembrane domain. To test this hypothesis, we made a construct coding for a non-HA tagged version of the 38 aa TLR4 transmembrane domain. Over-expression of this non-tagged TLR4 transmembrane domain competed with the HA-tagged full length TLR4 and inhibited its translocation to the cell membrane upon cotransfection with CD79a and CD79b (Figure 7A-D). Therefore, the TLR4/BCR interaction in HEK293 cells is mediated by the TLR4 transmembrane domain.
###end p 38
###begin title 39
TLR4/BCR associate through the TLR4 transmembrane region.
###end title 39
###begin p 40
###xml 89 99 89 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">left panel</italic>
###xml 121 132 121 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">right panel</italic>
###xml 161 169 161 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g005">Figure 5</xref>
HEK293 cells were co-transfected with truncated or full length TLR4 constructs with BCR (left panel) or BCR+CD79a/CD79b (right panel). Cells were prepared as in Figure 5 and all panels represent the overlay of green (anti-HA staining) and red (anti-IgM staining) channels. The HA-tagged TLR4 TM-IC construct (A-B), TLR4 TM-EC construct (C-D), as well as the TLR4 TM region alone (E-F) each translocated to the cell surface with expression of surface IgM.
###end p 40
###begin title 41
The TLR4 transmembrane region competitively inhibits the TLR4/BCR association.
###end title 41
###begin p 42
###xml 287 295 287 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g005">Figure 5</xref>
###xml 562 564 562 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 562 564 562 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>WT</sup></italic>
###xml 932 941 928 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g005">figure 5C</xref>
###xml 946 947 942 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 565 569 <span type="species:ncbi:10090">mice</span>
A-D. HEK293 cells were co-transfected with HA-tagged full length TLR4, along with the BCR (A and C) or the BCR and CD79a/CD79b constructs (B and D). In addition, cells in C and D were also cotransfected with a construct coding for the unlabeled TLR4 TM region. Cells were prepared as in Figure 5 and all panels represent the overlay of green (anti-HA staining) and red (anti-IgM staining) channels. The non-tagged TLR4 TM construct competed with the HA-TLR4 TM-IC, inhibiting its translocation to the cell membrane (compare B to D). E. Purified B cells from TLR4WT mice were pre-incubated for 2 hr with peptides TM1 or TM2 corresponding to the transmembrane region of TLR4 or with a control peptide, activated with 1 microg/ml of LPS for 1 hr, and TLR4 was immunoprecipitated with a specific biotinylated antibody and captured on streptavidin-coated microplates. Bound IgM was detected with a specific HRP-conjugated antibody as in figure 5C. ** P<0.01 vs. control-treated group.
###end p 42
###begin p 43
###xml 190 199 190 199 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4B</bold>
###xml 190 199 190 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g004"><bold>Figure 4B</bold></xref>
###xml 729 738 725 734 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 7E</bold>
###xml 729 738 725 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g007"><bold>Figure 7E</bold></xref>
To analyze whether the TLR4/BCR interaction was also mediated by the TLR4 transmembrane domain in the membrane of LPS-activated B cells, we competed the pull-down of IgM and TLR4 molecules (Figure 4B) by preincubation with peptides coding for the TLR4 transmembrane domain (10 microM). Peptide TM1 corresponds to the 648-659 aa region of TLR4, while peptide TM2 corresponds to the 629-655 aa region of TLR4. As a control we used a peptide derived from HSP60 that shows a similar charge distribution (VLGGGCALLRCPALDSLTPANED). Preincubation with the TM1 or TM2 peptides, but not with a control peptide, led to a dose-dependent decrease in the IgM pulled down with biotinylated antibodies to TLR4 from LPS-activated cell extracts (Figure 7E). Thus, the TLR4 TM domain mediates the TLR4/BCR interaction on B-cells following exposure to LPS.
###end p 43
###begin title 44
Discussion
###end title 44
###begin p 45
###xml 1167 1171 1167 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Honjo1">[40]</xref>
###xml 1248 1252 1248 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Han1">[41]</xref>
###xml 1254 1258 1254 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Ueda1">[42]</xref>
###xml 1358 1370 1358 1370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003509-g003">Figures 3E&#8211;H</xref>
###xml 611 615 <span type="species:ncbi:10090">mice</span>
###xml 1427 1431 <span type="species:ncbi:10090">mice</span>
In this work we report that TLR4 synergizes with the BCR to control the induction of IgG3 antibodies to LPS. The control exerted by TLR4 in the induction of anti-LPS IgG is the result of synergism between TLR4 and BCR signaling pathways triggered with limiting amounts of LPS in the absence of T-cell help. This synergistic interaction manifested three characteristics: A) It was constrained by the specificity of the TLR involved; inactivating mutations in TLR4 did not decrease the induction of antibodies to a TLR2 ligand. B) It was shown to be MyD88-dependent; synergism was not observed in MyD88-deficient mice. C) It was mediated by interactions that depended on the transmembrane domain of TLR4 and the BCR. Taken together, our results show that synergism between TLR4 and the BCR lowers the threshold for IgG3 production by B cells expressing an LPS-reactive BCR. Note that the control exerted by TLR4 in the induction of anti-LPS IgG3 might operate at the level of the class-switch recombination (CSR) to IgG3 and/or the somatic hypermutation (SHM) of LPS-specific antibodies. Both CSR and SHM are mediated by the activation-induced cytidine deaminase (AID) [40], and AID expression levels have been shown to be regulated by TLR signaling [41], [42]. Although our data using in vitro activated purified B cells shows a direct effect of TLR4 on CSR (Figures 3E-H), the decreased levels of LPS-specific IgG3 observed in mice carrying a mutant TLR4 might reflect a decrease in both CSR and SHM.
###end p 45
###begin p 46
###xml 790 794 790 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Pasare1">[12]</xref>
###xml 885 889 885 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Hayashi1">[43]</xref>
###xml 1004 1008 1004 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Pasare1">[12]</xref>
###xml 1127 1131 1127 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Pasare1">[12]</xref>
###xml 1183 1187 1183 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Pasare1">[12]</xref>
Our results support a role for TLRs in controlling the antibody response to TLR-ligands under conditions where the antigen is present in limiting amounts. Accordingly, natural IgG3 (and to a lesser extent natural IgG1) antibodies to LPS could only be detected in animals harboring a functional TLR4/MyD88 pathway. TLR-dependency, however, was restricted to control of production of IgG3 antigen specific antibodies, since we detected no association between anti-LPS IgM levels and the presence of a functional TLR4/MyD88 pathway. It has been recently reported that MyD88-dependent signaling in B cells is required for the generation of IgM and IgG1 antibodies to the TLR5 ligand flagellin, while MyD88 signaling in non-B cells might be needed for the generation of specific IgG3 antibodies [12]. Flagellin, however, is a bacterial protein that in addition to its role as a TLR5 ligand [43] also provides T-cell epitopes and consequently T-cell help for the induction of an anti-flagellin B-cell response [12]; moreover, to study the induction of the anti-flagellin antibody response the authors complexed the immunogen to alum [12]. Nevertheless, the results of Pasare and Medzhitov [12] and our own work suggest that TLR signaling in B cells controls aspects of the B cell response to TLR ligands.
###end p 46
###begin p 47
###xml 209 212 209 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Christensen1">[7]</xref>
###xml 214 217 214 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Ehlers1">[8]</xref>
###xml 219 222 219 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-He1">[9]</xref>
###xml 497 501 497 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Leifer1">[44]</xref>
###xml 817 821 817 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Chaturvedi1">[39]</xref>
###xml 1168 1173 <span type="species:ncbi:10090">mouse</span>
###xml 1178 1183 <span type="species:ncbi:9606">human</span>
Synergistic signaling has also been shown for the BCR and TLR9, and the dual engagement of these receptors is implicated in the triggering of IgM to IgG switching events and activation of autoreactive B cells [7], [8], [9]. Co-signaling seems to depend on physical interaction, either direct or indirect, in the case of TLR4/BCR, but may be independent of physical association in the case of TLR9. Endogenous TLR9 is sequestered in intracellular compartments in both resting and activated B-cells [44], supporting the notion that synergism is generated downstream of receptor-ligand binding events. Recently, however, Chaturvedi et al demonstrated that the subcellular location of TLR9 is shifted to compartments containing the internalized BCR in B cells following cross-linking of the BCR on the surface by antigen [39]. Thus, TLR9 and BCR may associate in subcellular compartments although the fact that the TLR4/BCR association mapped to the TLR4 TM domain in our study, suggests that this interaction with the BCR, whether directly or through additional partners, may be unique to TLR4. The TLR4 TM domain is highly conserved across species (80% homology between mouse and human), but there is little sequence similarity between TM domains of different TLR family members. The structural motifs that mediate the BCR/TLR4 interaction are therefore likely to be absent from other TLR TM domains. Thus, the synergism of the BCR with TLR4 seems to operate following rules different from those governing the crosstalk with other TLRs.
###end p 47
###begin p 48
###xml 292 296 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Divanovic1">[45]</xref>
Conversely, intermolecular associations seem to play a central role in the regulation of TLR4-dependent signal transduction and the response to LPS. It has been recently been reported that TLR4 interacts in DC with RP105, and this interaction results in the modulation of the response to LPS [45]. Although it has still to be proven that this mechanism is operative in B cells, it suggests that the partition of TLR4 between different interacting partners might play a role in modulating the B-cell response to LPS.
###end p 48
###begin p 49
###xml 108 112 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Spellman1">[46]</xref>
###xml 844 848 844 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Pasare1">[12]</xref>
###xml 850 854 850 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Kinoshita1">[47]</xref>
The mitogenic properties of LPS and its T-cell independence were described long before TLRs were discovered [46]. Our results provide a new molecular understanding for how IgG antibodies to LPS arise. The interaction of TLR4 with an LPS-reactive BCR results in a synergistic signal that induces IgG3 and IL-10 production, in the absence of T-cell help. Although the synergistic signal may be achieved by surface co-ligation of the BCR and TLR4 in the absence of an association of the receptors, the intimate relationship we describe enhances the sensitivity to the signal, allowing IgG3 antibodies to arise in a setting of very low circulating levels of LPS. Sub-mitogenic levels of LPS might also impact upon other functions of B-cells through BCR-TLR4 synergy, such as antigen uptake and presentation to T-cells and antibody somatic mutation [12], [47].
###end p 49
###begin p 50
###xml 287 291 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Abbas1">[48]</xref>
###xml 423 427 423 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Gianotti1">[49]</xref>
###xml 558 565 558 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 569 583 569 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. typhimurium</italic>
###xml 617 621 617 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Hopkins1">[50]</xref>
###xml 623 627 623 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Hopkins2">[51]</xref>
###xml 734 738 734 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Agnese1">[52]</xref>
###xml 558 565 <span type="species:ncbi:562">E. coli</span>
###xml 569 583 <span type="species:ncbi:90371">S. typhimurium</span>
###xml 612 616 <span type="species:ncbi:10090">mice</span>
###xml 686 692 <span type="species:ncbi:9606">humans</span>
The control of the induction of specific IgG3 antibodies triggered by limiting amounts of LPS might be clinically important. IgG3 antibodies contribute to the control of viral and bacterial infections through opsonization, complement fixation, and FcR mediated activation of neutrophils [48]. IgG3 anti-LPS antibodies have also been described to sequester LPS in the circulation thereby preventing or reducing its toxicity [49]. Although other mechanisms might also be involved, a lack of TLR4-BCR synergism may contribute to the increased susceptibility to E. coli or S. typhimurium infection in TLR4 deficient mice [50], [51], and to the increased risk of gram-negative infections in humans carrying inactivating TLR4 polymorphisms [52]. Thus, the synergistic signaling between the BCR and innate receptors may be a general property of B-cell physiology important for the generation of microbe-specific antibodies in the early stages of an immune response when antigen specific T cell help is not yet available. These synergistic interactions are potential targets for the design of new vaccines aimed at exploiting the innate-adaptive cross-talk to provide fast and effective protective immunity against pathogens.
###end p 50
###begin title 51
Materials and Methods
###end title 51
###begin title 52
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 52
###begin p 53
###xml 197 199 197 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">++</sup>
###xml 222 229 222 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lps-del</sup>
###xml 222 229 222 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>lps-del</sup></italic>
###xml 257 260 257 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">del</sup>
###xml 257 260 257 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>del</sup></italic>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
NOD/LtJ, C3HeB/FeJ and C3H/HeJ mice (Jackson Laboratories, Maine, USA) were bred and maintained in the spf animal facility of the Weizmann Institute of Science. C57BL/10 (herein referred to as TLR4++) and C57BL/10ScNJ-Tlr4lps-del (herein referred to as TLR4del) were from The Jackson Laboratory and were housed in the spf of Harvard Medical School. All experimental protocols were approved by the Institutional Animal Care and Use Committees of the respective institutions.
###end p 53
###begin title 54
Sera
###end title 54
###begin p 55
Blood was taken from the lateral tail vein and sera was stored at -20degreesC.
###end p 55
###begin title 56
ELISA assay
###end title 56
###begin p 57
###xml 34 41 34 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 474 478 459 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Scott1">[22]</xref>
###xml 34 41 <span type="species:ncbi:562">E. coli</span>
###xml 522 527 <span type="species:ncbi:10090">mouse</span>
Antibodies to gel purified LPS of E. coli 055:B5 (Sigma, MO, USA, product #L2637) were measured by ELISA. Plates (Maxisorb Nunc, Denmark) coated overnight with 50 ng/well of LPS were blocked with 1% BSA for 1 hr at 37degreesC. Serum samples diluted 1/100, unless otherwise stated, were added to the plates and incubated for 2 hr at 37degreesC. For the measurement of IgG reactivity, serum samples were pre-treated with 0.05 M beta-mercaptoethanol to rule out masking by IgM [22]. Bound antibodies were detected using anti-mouse IgG or IgM (Jackson ImmunoResearch Labs. Inc.,West Grove, Pennsylvania, USA) or isotype-specific secondary antibodies (Southern Biotechnology Associates Inc, Birmingham, AL, USA) conjugated to alkaline phosphatase, and Sigma's substrate for alkaline phosphatase.
###end p 57
###begin title 58
C3H/HeJ X NOD/Ltj cross
###end title 58
###begin p 59
###xml 370 391 368 389 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">ACCTGATACTTATTGCTGGCT</named-content>
###xml 415 436 413 434 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCTAAGAAGGCGATACAATTC</named-content>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 56 60 <span type="species:ncbi:10090">mice</span>
###xml 134 138 <span type="species:ncbi:10090">mice</span>
###xml 194 198 <span type="species:ncbi:10090">mice</span>
###xml 1070 1074 <span type="species:ncbi:10090">mice</span>
F1 progeny of NOD female mice crossed with C3H/HeJ male mice were intercrossed and F2 tail vein DNA samples were screened to identify mice homozygous for the CCT-->CAT mutation found in C3H/HeJ mice. A 400 bp DNA fragment surrounding the ScrF1 restriction site (200 bp on each side) located 25 bp downstream of the point mutation was amplified using the upstream primer ACCTGATACTTATTGCTGGCT and the reverse primer GCTAAGAAGGCGATACAATTC. PCR products were cleaned, digested with ScrF1 (New England Biolabs, MA, USA), and separated on 3% agarose gels (Cambrex Bio Science Rockland Inc,, Rockland, ME, USA). The CCT-->CAT mutation causes a loss of a ScrF1 endonuclease site and therefore DNA samples homozygous for the mutation are digested at only one site and yield two products of equal length (200 bp). Homozygous wt PCR products are cut at two sites and yield two visible bands of equal intensity, one 200 bp in length and the other 175 bp. It follows that 75% of the products from DNA of heterozygote samples is 200 bp in length and 25% is 175 bp. Homozygous mutant mice were backcrossed for three generations onto the NOD/Ltj background.
###end p 59
###begin title 60
Conjugation of LPS to anti-IgM
###end title 60
###begin p 61
###xml 22 26 <span type="species:ncbi:9925">Goat</span>
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
LPS was conjugated to Goat anti-mouse IgM (Jackson ImmunoResearch, West Grove, Pennsylvania, USA) using the heterobifunctional cross-linking reagent EMCH (Pierce, Rockford, IL, USA). The anti-IgM was thiolated using 2-Iminotiholane HCl at a 5-fold molar excess of thiolane to IgG. The reaction was purified by gel filtration with a Sephadex G-25 column (Pierce). Thiolated IgG was reacted with a 10-fold molar excess of EMCH for 2 h at RT. In parallel, LPS was oxidized with 10 mM sodium periodate (Sigma, Rehovot, Israel) for 30 min at RT. Oxidized LPS was added to the IgG-EMCH reaction at a 10-fold molar excess of hydrazide to LPS and reacted for 2 h at RT. The product was purified by size exclusion chromatography and LPS content of the conjugate was determined using the kinetic-turbidimetric LAL test method compared to a standard control (Biological Industries, Kibbutz Beit Haemek, Israel).
###end p 61
###begin title 62
B cell purification and activation
###end title 62
###begin p 63
###xml 47 51 <span type="species:ncbi:10090">mice</span>
Splenic B cells were purified from 2 month old mice using the MACS B Cell Isolation Kit (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany) according to the manufacturer's directions. The purity of the purified B cell fraction was >97% as determined by FACS analysis (data not shown).
###end p 63
###begin p 64
###xml 54 55 54 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 173 174 167 168 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 402 404 388 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 823 824 805 806 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 753 757 <span type="species:ncbi:9913">calf</span>
Purified B cells were cultured in quadriplicates (2x105/well) in round-bottom plates (Nunclon, Nunc, Denmark) for 72 hr at 37degreesC in a humidified atmosphere with 7.5% CO2, in the presence of different concentrations of alphaIgM, LPS or the [alphaIgM-LPS] conjugate. Stimulation medium was composed of Dulbecco's modified Eagle's medium (Gibco, Paisley, UK) supplemented with 2-mercaptoethanol (5 10-5 M, Sigma, Rehovot, Israel), L-glutamine (2 mM, Biological Industries, Kibbutz Beit Haemek, Israel), sodium pyruvate (1 mM, Sigma, Rehovot, Israel), penicilin and streptomycin (100 u/ml and 100 microg/ml, respectively; Biological Industries, Kibbutz Beit Haemek, Israel), non-essential amino acids (1% v/v, Bio Lab, Jerusalem, Israel), and 5% fetal calf serum (Grand Island Biological Company, Grand Island, NY, USA). [3H]thymidine (0.5 microCi of 5 mCi/mmol; Amersham, England) was added to the cultures for the last 18 hr of incubation. Thereafter, supernatants were collected, cells were harvested and the cpm were counted. The results are expressed as the stimulation index, the mean cpm of cultures incubated with stimulant divided by the mean cpm of cultures incubated in the absence of stimulant.
###end p 64
###begin title 65
IgG3 and IL-10 secretion
###end title 65
###begin p 66
B-cell culture supernatants were analysed for IgG3 and IL-10 content by ELISA using an appropriate pair of capture and detecting monoclonal antibodies (IL-10: Pharmingen, San Diego, USA; IgG3: Southern Biotechnology Associates Inc, Birmingham, AL, USA) according to the manufacturer's instructions. The results are expressed as pg/ml, based on a calibration curve constructed using known amounts of recombinant IgG3 (Southern Biotechnology Associates Inc) or IL-10 (Pharmingen).
###end p 66
###begin title 67
Immunoprecipitation and western blotting
###end title 67
###begin p 68
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1086 1089 1086 1089 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">450</sub>
Purified B cells (2x106) were lysed for 15 min on ice in 0.1 ml lysis buffer containing 1% digitonin (Sigma, Rehovot, Israel). Insoluble material was removed by centrifugation at 10.000 g for 10 min at 4 C. After pre-clearing of the lysate with Protein G-plus Agarose beads (Santa Cruz Biotechnology Inc., Santa Cruz, California, USA) the IgM molecules were precipitated using biotinylated anti-IgM antibodies (Jackson ImmunoResearch Inc.) or biotinylated anti-TLR4 (eBioscience, San Diego California, USA) followed by ON incubation with streptavidin agarose beads (Sigma). The beads were washed with lysis buffer, boiled, and the protein supernatant run in a 10-15% SDS-PAGE and analyzed by western blot using HRP conjugated antibody to IgM (Jackson ImmunoResearch Labs. Inc.) or TLR4 (eBioscience, USA) and the Western Blotting Luminol Reagent (Santa Cruz Biotechnology Inc.). Alternatively, lysates were precipitated with biotinylated anti-TLR4 and incubated on streptavidin coated plates ON. HRP-conjugated anti-IgM was used to reveal bound complexes using and OD was recorded at OD450. We used the following unrelated peptide as a control: VLGGGCALLRCPALDSLTPANED.
###end p 68
###begin title 69
Confocal microscopy
###end title 69
###begin p 70
###xml 388 395 380 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 388 395 <span type="species:ncbi:562">E. coli</span>
###xml 531 534 <span type="species:ncbi:10116">rat</span>
Purified B-cells were incubated overnight with LPS (20 microg/ml) or left untreated, fixed with 4% para-formaldehyde for 15 min on ice and washed with PBS. The cells were divided into aliquots containing 50,000 cells per 100 microl and incubated with biotinylated Fab anti-IgM (Jackson ImmunoResearch Inc.), antibodies to TLR4 or RP105 (Santa Cruz Biotechnology Inc.), or FITC-conjugated E. coli LPS (Sigma). The cells were washed, incubated with streptavidin conjugated to Cy3 (Jackson ImmunoResearch Inc.) or Cy5-conjugated anti-rat antibodies (Jackson ImmunoResearch Inc.) and adhered onto Poly-lysine microscope slides (BDH Laboratory Supplies, Poole,UK). Immunofluorescence was viewed and analyzed using a Bio-Rad confocal microscope (Bio-Rad, Richmond, CA).
###end p 70
###begin title 71
Plasmids and cloning
###end title 71
###begin p 72
###xml 438 442 438 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003509-Boulianne1">[53]</xref>
pDUO-hMD2/CD14 and pUNO-hTLR4HA (encoding HA-tagged TLR4) were purchased from Invivogen (San Diego, CA). pDISPLAY encoding HA-tagged TLR9 was a gift from Dr. David Segal (National Cancer Institute, National Institutes of Health, Bethesda, MD). IgM mu and kappa chains, CD79a and CD79b were cloned using RT-PCR and inserted in-frame into pORF (Invivogen). RNA for mu and kappa chains was extracted from SP2/0 cells expressing anti-TNP IgM [53], a gift from Dr. Mark Shulman (University of Toronto, Toronto, Canada). RNA for CD79a and CD79b was extracted from the Burkitt lymphoma Raji cell line, a gift from Dr. Eithan Galun (Hadassah Medical Center, Jerusalem, Israel).
###end p 72
###begin title 73
Transfection and cell staining
###end title 73
###begin p 74
###xml 580 585 <span type="species:ncbi:9606">human</span>
###xml 757 762 <span type="species:ncbi:10090">mouse</span>
HEK293 cells were a gift from Dr. Eitan Galun (Hadassah Medical Center). For stable expression of HA-TLR4, cells were transfected in 6-well plates using TransIT LT1 transfection reagent according to the manufacturer's protocol (Mirus, Madison, WI) and then selected with Blasticidin S (10 microg/ml). For transient transfection cells were plated on coverslips overnight followed the next day by transient transfection of the desired plasmids using TransIT LT1 transfection reagent. The next day cells were fixed using 4% PFA in PBS, washed, and incubated with Cy5-conjugated anti-human IgM (Jackson immunoresearch laboratories Inc.), and monoclonal anti-HA (Covance Research Products, Berkeley, CA, USA), followed by secondary antibody Cy3-conjugated anti- mouse IgG (Jackson immunoresearch laboratories Inc.). Coverslips were mounted in 70% glycerol and visualized and analyzed using an Olympus FluoView 300 laser scanning confocal microscope.
###end p 74
###begin title 75
Statistical significance
###end title 75
###begin p 76
###xml 107 108 107 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
The Prism 4.0a program (GraphPad Software, La Jolla, CA, USA) was used for statistical analysis. Student's t-test, and one-way and two-way ANOVA tests were carried out to assay significant differences between the different experimental groups.
###end p 76
###begin title 77
Supporting Information
###end title 77
###begin p 78
(0.15 MB DOC)
###end p 78
###begin p 79
Click here for additional data file.
###end p 79
###begin p 80
(0.08 MB DOC)
###end p 80
###begin p 81
Click here for additional data file.
###end p 81
###begin p 82
(0.35 MB DOC)
###end p 82
###begin p 83
Click here for additional data file.
###end p 83
###begin p 84
(0.36 MB DOC)
###end p 84
###begin p 85
Click here for additional data file.
###end p 85
###begin p 86
(0.30 MB DOC)
###end p 86
###begin p 87
Click here for additional data file.
###end p 87
###begin p 88
###xml 53 56 53 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 66 69 66 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
We thank Prof. S. Akira for his gracious gift of TLR2-/- and MyD88-/- mice.
###end p 88
###begin title 89
References
###end title 89
###begin article-title 90
Molecular processes that regulate class switching.
###end article-title 90
###begin article-title 91
Class-switch recombination: interplay of transcription, DNA deamination and DNA repair.
###end article-title 91
###begin article-title 92
TLR signaling.
###end article-title 92
###begin article-title 93
Toll-like receptors control activation of adaptive immune responses.
###end article-title 93
###begin article-title 94
Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide.
###end article-title 94
###begin article-title 95
###xml 62 67 <span type="species:ncbi:9606">human</span>
Maintenance of serological memory by polyclonal activation of human memory B cells.
###end article-title 95
###begin article-title 96
###xml 66 72 <span type="species:ncbi:10090">murine</span>
Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus.
###end article-title 96
###begin article-title 97
TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE.
###end article-title 97
###begin article-title 98
###xml 65 70 <span type="species:ncbi:9606">human</span>
CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10.
###end article-title 98
###begin article-title 99
Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling.
###end article-title 99
###begin article-title 100
Immunology: Toll-like receptors and antibody responses.
###end article-title 100
###begin article-title 101
Control of B-cell responses by Toll-like receptors.
###end article-title 101
###begin article-title 102
###xml 39 59 <span type="species:ncbi:139">Borrelia burgdorferi</span>
###xml 68 74 <span type="species:ncbi:9606">humans</span>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice.
###end article-title 102
###begin article-title 103
Toll-like receptor signalling.
###end article-title 103
###begin article-title 104
Natural autoantibodies.
###end article-title 104
###begin article-title 105
###xml 8 13 <span type="species:ncbi:9606">human</span>
Natural human antibodies to gram-negative bacteria: immunoglobulins G, A, and M.
###end article-title 105
###begin article-title 106
A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria.
###end article-title 106
###begin article-title 107
Control of early viral and bacterial distribution and disease by natural antibodies.
###end article-title 107
###begin article-title 108
Natural antibodies and complement link innate and acquired immunity.
###end article-title 108
###begin article-title 109
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product.
###end article-title 109
###begin article-title 110
###xml 19 23 <span type="species:ncbi:10090">mice</span>
Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4).
###end article-title 110
###begin article-title 111
Determination of total and merecaptothanol-resistant antibody in the same serum sample.
###end article-title 111
###begin article-title 112
###xml 25 59 <span type="species:ncbi:45201">Pasteurella haemolytica serotype 1</span>
Monoclonal antibodies to Pasteurella haemolytica serotype 1 lipopolysaccharide: demonstration of antigenic similarities among several serotypes.
###end article-title 112
###begin article-title 113
The immunoglobulin class switch: beyond "accessibility".
###end article-title 113
###begin article-title 114
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
Autoantibody patterns in diabetes-prone NOD mice and in standard C57BL/6 mice.
###end article-title 114
###begin article-title 115
CpG motifs in bacterial DNA and their immune effects.
###end article-title 115
###begin article-title 116
###xml 20 26 <span type="species:ncbi:10090">murine</span>
###xml 52 68 <span type="species:ncbi:562">Escherichia coli</span>
Characterization of murine monoclonal antibodies to Escherichia coli J5.
###end article-title 116
###begin article-title 117
Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin.
###end article-title 117
###begin article-title 118
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3.
###end article-title 118
###begin article-title 119
Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex.
###end article-title 119
###begin article-title 120
The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells.
###end article-title 120
###begin article-title 121
Conventional and surrogate light chains differentially regulate Ig mu and Dmu heavy chain maturation and surface expression.
###end article-title 121
###begin article-title 122
###xml 68 87 <span type="species:ncbi:210">Helicobacter pylori</span>
Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells.
###end article-title 122
###begin article-title 123
Lipid rafts and B-cell activation.
###end article-title 123
###begin article-title 124
Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.
###end article-title 124
###begin article-title 125
T-bet: the Toll-bridge to class-switch recombination?
###end article-title 125
###begin article-title 126
Activation of autoreactive B cells by CpG dsDNA.
###end article-title 126
###begin article-title 127
TLR9 signals after translocating from the ER to CpG DNA in the lysosome.
###end article-title 127
###begin article-title 128
The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens.
###end article-title 128
###begin article-title 129
AID: how does it aid antibody diversity?
###end article-title 129
###begin article-title 130
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
Class switch recombination and somatic hypermutation in early mouse B cells are mediated by B cell and Toll-like receptors.
###end article-title 130
###begin article-title 131
T-independent activation-induced cytidine deaminase expression, class-switch recombination, and antibody production by immature/transitional 1 B cells.
###end article-title 131
###begin article-title 132
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5.
###end article-title 132
###begin article-title 133
TLR9 is localized in the endoplasmic reticulum prior to stimulation.
###end article-title 133
###begin article-title 134
Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105.
###end article-title 134
###begin article-title 135
###xml 55 64 <span type="species:ncbi:10090">nude mice</span>
###xml 68 84 <span type="species:ncbi:235">Brucella abortus</span>
Immune and mitogenic responses by BALB/c, C3H/HeJ, and nude mice to Brucella abortus bacterin and lipopolysaccharide.
###end article-title 135
###begin article-title 136
Linking class-switch recombination with somatic hypermutation.
###end article-title 136
###begin article-title 137
Experimental gut-derived endotoxaemia and bacteraemia are reduced by systemic administration of monoclonal anti-LPS antibodies.
###end article-title 137
###begin article-title 138
###xml 41 57 <span type="species:ncbi:562">Escherichia coli</span>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
Inheritance of susceptibility to induced Escherichia coli bladder and kidney infections in female C3H/HeJ mice.
###end article-title 138
###begin article-title 139
###xml 34 50 <span type="species:ncbi:562">Escherichia coli</span>
###xml 99 104 <span type="species:ncbi:10090">mouse</span>
Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains.
###end article-title 139
###begin article-title 140
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections.
###end article-title 140
###begin article-title 141
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
###xml 41 46 <span type="species:ncbi:9606">human</span>
Production of functional chimaeric mouse/human antibody.
###end article-title 141
###begin p 142
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 142
###begin p 143
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
###xml 288 293 <span type="species:ncbi:9606">Human</span>
Funding: Part of the study was supported by a grant from the Juvenile Diabetes Research Foundation International. Aspects of the study were funded by a grant from the Center for the Study of Emerging Diseases, Jerusalem. FJQ was supported by a long-term fellowship from the International Human Frontier Science Program Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 143

